Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-23-010638

President and CEO acquired 58,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stergiou Angelos M. President and CEO 2023-02-02 Grant or award +58,000 219,689 D
Derivatives
Stergiou Angelos M. President and CEO 2023-02-02 Grant or award · Stock Option (Right to Buy) +217,500 217,500 D
Loading xslF345X03/tm235353d7_4seq1.xml…